Vialwirebiotech, curated
November 21, 2026, 8:12 AM
October 16, 2026
- 12:00 PM · BioWorld12:00 PMCity Tx raises $200M in IPO to advance siRNA pipeline — BioWorld
- 12:00 PM · BioWorld12:00 PMEstuary wades into ADPKD with a $93M series A — BioWorld
- 10:29 AM · Pharmaceutical Technology10:29 AMLilly’s Foundayo wins EMA panel backing for obesity and type 2 diabetes — Pharmaceutical Technology
- 9:38 AM · STAT News9:38 AMSTAT+: RevMed’s pancreatic cancer drug nears European approval — STAT News
- 9:30 AM · Pharmaceutical Executive9:30 AM<![CDATA[FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease]]> — Pharmaceutical Executive